{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T04:13:12Z","timestamp":1793679192422,"version":"4.5.1"},"reference-count":48,"publisher":"BMJ","issue":"7","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2016,5,4]]},"published-print":{"date-parts":[[2016,7]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>\n                      In conjunction with the NILVAD trial, a European Multicentre Double-Blind Placebo Controlled trial of Nilvadipine in Mild-to-Moderate Alzheimer's disease (AD), there are four NILVAD substudies in which eligible NILVAD patients are also invited to participate. The main NILVAD protocol was previously published in\n                      <jats:italic>BMJ Open<\/jats:italic>\n                      (2014). The objectives of the NILVAD substudies are to determine whether frailty, cerebrospinal fluid (CSF), blood biomarker profile and Apolipoprotein E (APOE) status predict response to Nilvadipine, and to investigate the effect of Nilvadipine on cerebral blood flow and blood biomarkers.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>All participants who fulfil criteria for the main NILVAD study are eligible for participation in the NILVAD substudies. Participation is subject to informed consent and whether the substudy is available at a particular NILVAD study site. Each substudy entails extra measurements during the course of the main NILVAD study. For example, in the blood and genetic biomarkers substudy, extra blood (30\u2005mL) will be collected at week 0, week 13, week 52 and week 78, while in the cerebral blood flow substudy, participants will receive an MRI and transcranial Doppler measurements at week 0, week 26 and week 78. In the CSF substudy, 10\u2005mL CSF is collected at week 0 and week 78.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>All NILVAD substudies and all subsequent amendments have received ethical approval within each participating country, according to national regulations. Each participant provides written consent to participate. All participants remain anonymised throughout and the results of each substudy will be published in an international peer reviewed journal.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>EUDRACT 2012-002764-27; Pre-results.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2016-011584","type":"journal-article","created":{"date-parts":[[2016,7,19]],"date-time":"2016-07-19T22:33:55Z","timestamp":1468967635000},"page":"e011584","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":20,"title":["European multicentre double-blind placebo-controlled trial of Nilvadipine in mild-to-moderate Alzheimer's disease\u2014the substudy protocols: NILVAD frailty; NILVAD blood and genetic biomarkers; NILVAD cerebrospinal fluid biomarkers; NILVAD cerebral blood flow"],"prefix":"10.1136","volume":"6","author":[{"given":"Olga","family":"Meulenbroek","sequence":"first","affiliation":[{"name":"Radboud Alzheimer Centre; Radboud University Medical Centre, Nijmegen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"O'Dwyer","sequence":"additional","affiliation":[{"name":"Mercer's Institute for Research on Ageing, St James's Hospital, Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daan","family":"de Jong","sequence":"additional","affiliation":[{"name":"Radboud Alzheimer Centre; Radboud University Medical Centre, Nijmegen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerrita","family":"van Spijker","sequence":"additional","affiliation":[{"name":"Radboud Alzheimer Centre; Radboud University Medical Centre, Nijmegen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean","family":"Kennelly","sequence":"additional","affiliation":[{"name":"Trinity College Dublin (TCD), Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona","family":"Cregg","sequence":"additional","affiliation":[{"name":"Trinity College Dublin (TCD), Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel","family":"Olde Rikkert","sequence":"additional","affiliation":[{"name":"Radboud Alzheimer Centre; Radboud University Medical Centre, Nijmegen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laila","family":"Abdullah","sequence":"additional","affiliation":[{"name":"Roskamp Institute, Sarasota, Florida, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Wallin","sequence":"additional","affiliation":[{"name":"Goeteborgs Universitet (UGOT), Gothenburg, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cathal","family":"Walsh","sequence":"additional","affiliation":[{"name":"University College Dublin (UCD), Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Coen","sequence":"additional","affiliation":[{"name":"Mercer's Institute for Research on Ageing, St James's Hospital, Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rose Anne","family":"Kenny","sequence":"additional","affiliation":[{"name":"Mercer's Institute for Research on Ageing, St James's Hospital, Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie","family":"Daly","sequence":"additional","affiliation":[{"name":"University College Dublin (UCD), Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Segurado","sequence":"additional","affiliation":[{"name":"University College Dublin (UCD), Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Borjesson-Hanson","sequence":"additional","affiliation":[{"name":"Goeteborgs Universitet (UGOT), Gothenburg, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona","family":"Crawford","sequence":"additional","affiliation":[{"name":"Archer Pharmaceuticals Inc, Sarasota, Florida, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Mullan","sequence":"additional","affiliation":[{"name":"Archer Pharmaceuticals Inc, Sarasota, Florida, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ugo","family":"Lucca","sequence":"additional","affiliation":[{"name":"Department of Laboratory of Geriatric Neuropsychiatry, IRCCS\u2014Istituto di Ricerche Farmacologiche \u201cMario Negri\u201d (IRFMN), Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Banzi","sequence":"additional","affiliation":[{"name":"Department of Laboratory of Geriatric Neuropsychiatry, IRCCS\u2014Istituto di Ricerche Farmacologiche \u201cMario Negri\u201d (IRFMN), Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Pasquier","sequence":"additional","affiliation":[{"name":"Centre Hospitalier Regional et Universitaire de Lille (CHRU- LILLE), Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laetitia","family":"Breuilh","sequence":"additional","affiliation":[{"name":"Centre Hospitalier Regional et Universitaire de Lille (CHRU- LILLE), Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Riepe","sequence":"additional","affiliation":[{"name":"Universitaet Ulm, (UULM), Ulm, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janos","family":"Kalman","sequence":"additional","affiliation":[{"name":"Szegedi Tudomanyegyetem (SZEGED), Szeged, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7370-8630","authenticated-orcid":false,"given":"William","family":"Molloy","sequence":"additional","affiliation":[{"name":"Centre for Gerontology and Rehabilitation, University College Cork (UCC), Cork, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magda","family":"Tsolaki","sequence":"additional","affiliation":[{"name":"Aristotle University of Thessaloniki (AUTH), Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Howard","sequence":"additional","affiliation":[{"name":"Kings College London (KCL), London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Adams","sequence":"additional","affiliation":[{"name":"Kings College London (KCL), London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siobhan","family":"Gaynor","sequence":"additional","affiliation":[{"name":"Molecular Medicine Ireland (MMI), Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Lawlor","sequence":"additional","affiliation":[{"name":"Mercer's Institute for Research on Ageing, St James's Hospital, Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2016,7,19]]},"reference":[{"key":"2025120521423670000_6.7.e011584.1","doi-asserted-by":"publisher","DOI":"10.1093\/gerona\/glt013"},{"key":"2025120521423670000_6.7.e011584.2","doi-asserted-by":"publisher","DOI":"10.1159\/000353859"},{"key":"2025120521423670000_6.7.e011584.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2010.09.001"},{"key":"2025120521423670000_6.7.e011584.4","doi-asserted-by":"publisher","DOI":"10.1093\/gerona\/56.3.M146"},{"key":"2025120521423670000_6.7.e011584.5","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.050051"},{"key":"2025120521423670000_6.7.e011584.6","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2318-8-24"},{"key":"2025120521423670000_6.7.e011584.7","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.2010.02764.x"},{"key":"2025120521423670000_6.7.e011584.8","doi-asserted-by":"publisher","DOI":"10.1016\/0021-9681(87)90171-8"},{"key":"2025120521423670000_6.7.e011584.9","doi-asserted-by":"publisher","DOI":"10.5014\/ajot.53.5.471"},{"key":"2025120521423670000_6.7.e011584.10","doi-asserted-by":"publisher","DOI":"10.1093\/geront\/46.4.503"},{"key":"2025120521423670000_6.7.e011584.11","first-page":"448","article-title":"The Alzheimer's disease assessment scale: an instrument for assessing treatment efficacy","volume":"19","author":"Mohs","year":"1983","journal-title":"Psychopharmacol Bull"},{"key":"2025120521423670000_6.7.e011584.12","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.3109\/10641969909052196","article-title":"Effects of nilvadipine on cytokine-levels and soluble factors in collagen disease complicated with essential hypertension","volume":"21","author":"Kagawa","year":"1999","journal-title":"Clin Exp Hypertens"},{"key":"2025120521423670000_6.7.e011584.13","doi-asserted-by":"crossref","first-page":"149","DOI":"10.2119\/molmed.2010.00180","article-title":"Selective antihypertensive dihydropyridines lower Abeta accumulation by targeting both the production and the clearance of Abeta across the blood-brain barrier","volume":"17","author":"Paris","year":"2011","journal-title":"Mol Med"},{"key":"2025120521423670000_6.7.e011584.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2003.11.061"},{"key":"2025120521423670000_6.7.e011584.15","doi-asserted-by":"crossref","first-page":"432","DOI":"10.2119\/molmed.2009.00083","article-title":"Serum Abeta levels as predictors of conversion to mild cognitive impairment\/Alzheimer disease in an ADAPT subcohort","volume":"15","author":"Abdullah","year":"2009","journal-title":"Mol Med"},{"key":"2025120521423670000_6.7.e011584.16","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2217\/bmm.09.84","article-title":"Blood-based biomarkers of Alzheimer's disease: challenging but feasible","volume":"4","author":"Thambisetty","year":"2010","journal-title":"Biomark Med"},{"key":"2025120521423670000_6.7.e011584.17","doi-asserted-by":"publisher","DOI":"10.1159\/000321984"},{"key":"2025120521423670000_6.7.e011584.18","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2003.12.023"},{"key":"2025120521423670000_6.7.e011584.19","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1002\/gps.2735","article-title":"Apolipoprotein E genotype-specific short-term cognitive benefits of treatment with the antihypertensive nilvadipine in Alzheimer's patients-an open-label trial","volume":"27","author":"Kennelly","year":"2012","journal-title":"Int J Geriatr Psychiatry"},{"key":"2025120521423670000_6.7.e011584.20","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2013.08.001"},{"key":"2025120521423670000_6.7.e011584.21","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(15)70016-5"},{"key":"2025120521423670000_6.7.e011584.22","doi-asserted-by":"publisher","DOI":"10.1159\/000245156"},{"key":"2025120521423670000_6.7.e011584.23","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(03)00530-1"},{"key":"2025120521423670000_6.7.e011584.24","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2009.1064"},{"key":"2025120521423670000_6.7.e011584.25","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1159\/000077737","article-title":"CT brain findings in clinical dementia investigation\u2014underestimation of mixed dementia","volume":"18","author":"N\u00e4gga","year":"2004","journal-title":"Dement Geriatr Cogn Disord"},{"key":"2025120521423670000_6.7.e011584.26","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.52.5.1090"},{"key":"2025120521423670000_6.7.e011584.27","doi-asserted-by":"crossref","first-page":"665","DOI":"10.3233\/JAD-2011-110566","article-title":"Cerebrospinal fluid matrix metalloproteinases and tissue inhibitor of metalloproteinases in combination with subcortical and cortical biomarkers in vascular dementia and Alzheimer's disease","volume":"27","author":"Bjerke","year":"2011","journal-title":"J Alzheimers Dis"},{"key":"2025120521423670000_6.7.e011584.28","doi-asserted-by":"publisher","DOI":"10.1007\/BF02815140"},{"key":"2025120521423670000_6.7.e011584.29","doi-asserted-by":"publisher","DOI":"10.1038\/jcbfm.2011.69"},{"key":"2025120521423670000_6.7.e011584.30","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00022.2002"},{"key":"2025120521423670000_6.7.e011584.31","doi-asserted-by":"publisher","DOI":"10.1097\/MNM.0b013e32804c58aa"},{"key":"2025120521423670000_6.7.e011584.32","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)60235-8"},{"key":"2025120521423670000_6.7.e011584.33","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2014-006364"},{"key":"2025120521423670000_6.7.e011584.34","doi-asserted-by":"crossref","unstructured":"Emmerich T , Abdullah L , Crynen G , et al . Plasma lipidomic profiling in a military population of Mild Traumatic Brain Injury and Post-Traumatic Stress Disorder with APOE E \u025b4 dependent effect. J Neurotrauma 2016. [epub ahead of print]. doi:10.1089\/neu.2015.4061","DOI":"10.1089\/neu.2015.4061"},{"key":"2025120521423670000_6.7.e011584.35","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2119\/molmed.2008.00118","article-title":"High serum Abeta and vascular risk factors in first-degree relatives of Alzheimer's disease patients","volume":"15","author":"Abdullah","year":"2009","journal-title":"Mol Med"},{"key":"2025120521423670000_6.7.e011584.36","doi-asserted-by":"publisher","DOI":"10.1096\/fj.14-258228"},{"key":"2025120521423670000_6.7.e011584.37","doi-asserted-by":"crossref","unstructured":"Katz MH . Multivariable analysis: a practical guide for clinicians and public health researchers. Cambridge, New York: Cambridge University Press, 2011.","DOI":"10.1017\/CBO9780511974175"},{"key":"2025120521423670000_6.7.e011584.38","doi-asserted-by":"publisher","DOI":"10.1038\/jcbfm.2013.135"},{"key":"2025120521423670000_6.7.e011584.39","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1326-8-38"},{"key":"2025120521423670000_6.7.e011584.40","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3182309fa5"},{"key":"2025120521423670000_6.7.e011584.41","doi-asserted-by":"publisher","DOI":"10.1016\/S0197-4580(03)00086-1"},{"key":"2025120521423670000_6.7.e011584.42","doi-asserted-by":"publisher","DOI":"10.1038\/jhh.2010.54"},{"key":"2025120521423670000_6.7.e011584.43","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2008.01.012"},{"key":"2025120521423670000_6.7.e011584.44","doi-asserted-by":"publisher","DOI":"10.3389\/neuro.09.016.2010"},{"key":"2025120521423670000_6.7.e011584.45","doi-asserted-by":"publisher","DOI":"10.1016\/j.mri.2011.02.030"},{"key":"2025120521423670000_6.7.e011584.46","doi-asserted-by":"publisher","DOI":"10.1002\/hbm.10062"},{"key":"2025120521423670000_6.7.e011584.47","doi-asserted-by":"publisher","DOI":"10.1109\/42.906424"},{"key":"2025120521423670000_6.7.e011584.48","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1109\/TSP.2008.2005752","article-title":"Variational Bayesian inference for a nonlinear forward model","volume":"57","author":"Chappell","year":"2009","journal-title":"IEEE Transactions on Signal Processing"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2016-011584","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T05:42:44Z","timestamp":1764999764000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2016-011584"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":48,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2016,7,19]]},"published-print":{"date-parts":[[2016,7]]}},"alternative-id":["10.1136\/bmjopen-2016-011584"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2016-011584","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7]]}}}